Classes > 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
Page last updated: 2024-08-05 12:42:56
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ChEBI ID: 194135
Members (1)
| Member | Definition | Role |
|---|
| levofloxacin | An optically active form of ofloxacin having (S)-configuration; an inhibitor of bacterial topoisomerase IV and DNA gyrase. | levofloxacin |
Research
Studies (4,158)
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|
| pre-1990 | 2 (0.05) | 18.7374 |
| 1990's | 300 (7.22) | 18.2507 |
| 2000's | 1,450 (34.87) | 29.6817 |
| 2010's | 1,737 (41.77) | 24.3611 |
| 2020's | 669 (16.09) | 2.80 |
Study Types
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|
| Trials | 581 (13.37%) | 5.53% |
| Reviews | 279 (6.42%) | 6.00% |
| Case Studies | 575 (13.23%) | 4.05% |
| Observational | 37 (0.85%) | 0.25% |
| Other | 2,874 (66.13%) | 84.16% |